Tetracel (American Home Products).

Abstract

American Home Products (AHP) is developing Tetracel as a vaccine for children (aged 12 to 18 months) against diphtheria, tetanus, pertussis and Haemophilus influenzae type B (Hib) [275146]. The components are contained in AHP's two currently marketed vaccines. ACEL-Immune contains diphtheria and tetanus toxoids with acellular pertussis vaccine adsorbed, and HibTITER contains the Haemophilus influenzae B conjugate vaccine (diphtheria CRM197 protein conjugate) [239655]. As of January 2000, Lehman Brothers predicted Tetracel to be approved in the US during 2000 [354434].

• Authors: D H Jones
• Journal: Current opinion in investigational drugs (London, England : 2000) (Curr Opin Investig Drugs) Vol. 2 Issue 1 Pg. 50-2 (Jan 2001) ISSN: 1472-4472 [Print] England
• PMID: 11527012 (Publication Type: Journal Article)

Chemical References

• Diphtheria-Tetanus-Pertussis Vaccine
• Haemophilus Vaccines
• Tetracel
• Vaccines, Conjugate

Topics

• Clinical Trials as Topic
• Diphtheria-Tetanus-Pertussis Vaccine (adverse effects, immunology)
• Haemophilus Vaccines (adverse effects, immunology)
• Humans
• Immunization
• Vaccines, Conjugate (immunology)